Future research should focus on unveiling the molecular mechanisms through which RANKL gene polymorphisms influence RA susceptibility and on developing targeted therapies that intervene in the RANK/RANKL/osteoprotegerin pathway. Here, TNFSF11 is linked to rheumatoid arthritis.